Vermillion & White Wealth Management Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-55
Closed -$59.1K 325
2025
Q4
$59.1K Buy
55
+20
+57% +$19.1K 0.03% 136
2025
Q3
$26.7K Buy
35
+16
+84% +$11.9K 0.02% 219
2025
Q2
$14.8K Hold
19
0.01% 261
2025
Q1
$15.7K Hold
19
0.01% 227
2024
Q4
$14.7K Hold
19
0.01% 213
2024
Q3
$16.8K Buy
19
+9
+90% +$8.09K 0.01% 189
2024
Q2
$9.05K Hold
10
0.01% 231
2024
Q1
$7.78K Hold
10
0.01% 231
2023
Q4
$5.83K Buy
+10
New +$5.84K 0.01% 197

Other funds holding LLY

Vermillion & White Wealth Management Group's LLY Position: Q1 2026 in Review

Vermillion & White Wealth Management Group sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 55 shares — an estimated $59.1K sold.

Vermillion & White Wealth Management Group first reported a position in LLY in Q4 2023 and held it in 9 quarters. The position peaked at $59.1K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Vermillion & White Wealth Management Group reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Vermillion & White Wealth Management Group sold 55 Eli Lilly shares in Q1 2026, an estimated $59.1K.
  • Vermillion & White Wealth Management Group first reported a position in Eli Lilly in Q4 2023 and held it in 9 quarters.
  • Vermillion & White Wealth Management Group's Eli Lilly position peaked at $59.1K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Vermillion & White Wealth Management Group's 13F filing for Q1 2026, filed 14 May 2026.